BioCer HaemoCer™ Haemostatic Powder - HSA Registration DE0013002
Access comprehensive regulatory information for BioCer HaemoCer™ Haemostatic Powder in the Singapore medical device market through Pure Global AI's free database. This CLASS D medical device is registered under HSA registration number DE0013002 and owned by BioCer Entwicklungs-GmbH. The device was registered on May 23, 2013.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
HaemoCer™ is an adjunct hemostatic agent for use in surgical procedures, when control of bleeding from capillary, venous, or arteriolar vessels by pressure, ligature and other conventional procedures is either ineffective or impractical.